Alpine Bank Wealth Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
Alpine Bank Wealth Management's EW Position: Q2 2026 in Review
Alpine Bank Wealth Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 450 shares worth $40.7K. The stake represents 0.01% of the portfolio and ranks #261 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in EW as recently as Q3 2025.
Alpine Bank Wealth Management first reported a position in EW in Q3 2024 and has held it in 5 quarters since. The position peaked at $108K in Q3 2025. 775 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Alpine Bank Wealth Management held 450 shares of Edwards Lifesciences worth $40.7K as of Q2 2026.
- Edwards Lifesciences was a new Alpine Bank Wealth Management position in Q2 2026.
- Edwards Lifesciences made up 0.01% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #261 holding.
- Alpine Bank Wealth Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 5 quarters since.
- Alpine Bank Wealth Management's Edwards Lifesciences position peaked at $108K in Q3 2025.
- 775 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.